Pluri (PLUR) Cash from Operations (2010 - 2025)
Pluri (PLUR) posted quarterly Cash from Operations of 5205000.0 for Q4 2025, down 12.47% year-over-year from 5946368.8 in Q4 2024, and up 4.11% quarter-over-quarter from 5428000.0 in Q3 2025.
Pluri (PLUR) Cash from Operations (2010 - 2025) Analysis & Trends
Pluri (PLUR) has reported Cash from Operations for 16 consecutive years, with 5205000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash from Operations fell 12.47% year-over-year to 5205000.0; the TTM figure through Dec 2025 stood at 20152000.0 (down 17.12% YoY), while the FY2025 annual figure was 18211000.0, down 1.05% from the prior year.
- Cash from Operations advanced to 5205000.0 in Q4 2025 per PLUR's latest filing, from 5428000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 2897000.0 in Q2 2023 and bottomed at 9863000.0 in Q4 2021.
- Historically, Cash from Operations has averaged 6157450.0 across 5 years, with a median of 5642500.0 in 2023.
- Annual changes were most pronounced in 2021 — Cash from Operations slumped 51.8% — and 2023, when it surged 65.62%.
- Pluri's Cash from Operations stood at 9863000.0 in 2021, then surged by 36.33% to 6280000.0 in 2022, then jumped by 41.89% to 3649000.0 in 2023, then declined by 26.83% to 4628000.0 in 2024, then dropped by 12.47% to 5205000.0 in 2025.
- Business Quant data shows PLUR's Cash from Operations at 5205000.0 in Q4 2025, 5428000.0 in Q3 2025, and 5216000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 | -5.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.21 Mn |
| Dec 31, 2025 | -5.21 Mn |
| Sep 30, 2025 | -5.43 Mn |
| Sep 30, 2025 | -5.43 Mn |
| Jun 30, 2025 | -5.22 Mn |
| Jun 30, 2025 | -5.22 Mn |
| Mar 31, 2025 | -4.30 Mn |
| Mar 31, 2025 | -4.30 Mn |
| Dec 31, 2024 | -4.63 Mn |
| Dec 31, 2024 | -4.63 Mn |
| Sep 30, 2024 | -4.06 Mn |
| Sep 30, 2024 | -4.06 Mn |
| Jun 30, 2024 | -4.31 Mn |
| Jun 30, 2024 | -4.31 Mn |
| Mar 31, 2024 | -4.20 Mn |
| Mar 31, 2024 | -4.20 Mn |
| Dec 31, 2023 | -3.65 Mn |
| Dec 31, 2023 | -3.65 Mn |
| Sep 30, 2023 | -5.86 Mn |
| Sep 30, 2023 | -5.86 Mn |